학술논문
Successful fractionated undiluted doses of COVID‐19 vaccine in five cases of suspected allergic reactions to the first dose
Document Type
Report
Author
Source
Clinical Case Reports. October 2022, Vol. 10 Issue 10
Subject
Language
English
Abstract
INTRODUCTION Since the outbreak of the coronavirus disease (COVID‐19), the implementation of public health practices and administration of the complete vaccination cycle helped to prevent the infection spread.[sup.1] Anaphylactic reactions, [...]
: After a suspected allergic reaction to first dose of mRNA COVID‐19 vaccine, given the PEG skin tests negativity and tolerance in vivo to PEG containing drugs, five patients were vaccinated with the second dose of Pfizer‐Biontech undergoing a fractional protocol, with antihistamine premedication, without presenting immediate or delayed reactions.
: After a suspected allergic reaction to first dose of mRNA COVID‐19 vaccine, given the PEG skin tests negativity and tolerance in vivo to PEG containing drugs, five patients were vaccinated with the second dose of Pfizer‐Biontech undergoing a fractional protocol, with antihistamine premedication, without presenting immediate or delayed reactions.